Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study

被引:1
|
作者
Naderian, Mohammadreza [1 ,2 ]
Kolahdoozan, Shadi [1 ]
Sharifi, Amir Sina [1 ]
Garmaroudi, Gholamreza [3 ]
Yaseri, Mehdi [4 ]
Poustchi, Hossein [1 ]
Sohrabpour, Amir Ali [1 ]
机构
[1] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Hlth Educ & Promot, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran
关键词
Cut-off; lean; metabolic syndrome X; Non-alcoholic fatty liver disease; non-obese; RISK-FACTORS; INSULIN-RESISTANCE; ADULT-POPULATION; ADIPOSE-TISSUE; NORMAL-WEIGHT; VISCERAL FAT; NONOBESE; OBESITY; STEATOHEPATITIS; OVERWEIGHT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent data has proven that the WHO (world health organization) cut-off for obesity is not applicable to the Asian population. This study aims to estimate the prevalence of lean NAFLD (non-alcoholic fatty liver disease) in the capital of Iran and extract probable predictors for this growing heath issue in this population. Methods: This is a population-based cross-sectional study on apparently healthy subjects over 18 years of age. The participants were interviewed for baseline demographic and clinical information. They were subsequently referred for physical examination and blood sampling. NAFLD was diagnosed using abdominal ultrasonography by a single expert radiologist. Results: Of 927 eligible participants who entered the study, 314 were lean; BMI (body mass index) <25 kg/m(2). The prevalence of NAFLD was 17.52% (95% Exact CI: 13.48%-22.18%). BMI, SBP (systolic blood pressure), DBP (diastolic blood pressure), total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein) and triglyceride were significantly different in patients with NAFLD. In the final multiple analysis, higher levels of triglyceride, upper SBP and higher BMI even in the range of less than 25 kg/m2 were independent predictors of NAFLD in lean participants. In lean participants with more components of metabolic syndrome, the prevalence of NAFLD increased significantly (all P < 0.01). BMI cut-offs in men and women along with waist circumference cut-off in men could significantly predict the presence of NAFLD in lean patients. After comparing these values, McNemar test showed that BMI cut-offs are more robust than waist circumference cut-offs for predicting the presence of NAFLD in lean subjects (P < 0.01). Conclusion: The prevalence of NAFLD in lean subjects in a sample of Iranian population is 17.52%. Hypertriglyceridemia, higher SBP, and higher BMI especially over 23.2 are independent factors associated with the presence of NAFLD in lean subjects.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [1] Beverage consumption in patients with metabolic syndrome and its association with non-alcoholic fatty liver disease: a cross-sectional study
    Kositamongkol, Chayanis
    Ngaohirunpat, Sorawis
    Samchusri, Supawit
    Chaisathaphol, Thanet
    Srivanichakorn, Weerachai
    Washirasaksiri, Chaiwat
    Auesomwang, Chonticha
    Sitasuwan, Tullaya
    Tinmanee, Rungsima
    Sayabovorn, Naruemit
    Charatcharoenwitthaya, Phunchai
    Phisalprapa, Pochamana
    FRONTIERS IN NUTRITION, 2024, 11
  • [2] Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study
    Khayyat, Yasir Mohammed
    PHYSIOLOGICAL REPORTS, 2021, 9 (14):
  • [3] Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study
    Adrian, Therese
    Sorensen, Ida M. H.
    Knop, Filip K.
    Bro, Susanne
    Ballegaard, Ellen L. F.
    Nordestgaard, Borge G.
    Fuchs, Andreas
    Kofoed, Klaus F.
    Kuhl, Jorgen T.
    Sigvardsen, Per E.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1927 - 1934
  • [4] Increased Prevalence of Colorectal Adenomas in Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
    Blackett, John W.
    Verna, Elizabeth
    Lebwohl, Benjamin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S155 - S155
  • [5] Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study
    Paudel, Mukesh S.
    Tiwari, Awadhesh
    Mandal, Amrendra
    Shrestha, Barun
    Kafle, Paritosh
    Chaulagai, Baikuntha
    Sudhamshu, K. C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [6] Comparing the prevalence of metabolic disorders in alcoholic and non-alcoholic fatty liver disease
    Li, Feng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 190 - 190
  • [7] Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study
    Tang, Yi
    Chen, Xu
    Chen, Qian
    Xiao, Jinghe
    Mi, Jiaxin
    Liu, Qiannan
    You, Yiran
    Chen, Yuming
    Ling, Wenhua
    NUTRITION & METABOLISM, 2022, 19 (01)
  • [8] Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study
    Yi Tang
    Xu Chen
    Qian Chen
    Jinghe Xiao
    Jiaxin Mi
    Qiannan Liu
    Yiran You
    Yuming Chen
    Wenhua Ling
    Nutrition & Metabolism, 19
  • [9] Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study
    Gkolfakis, Paraskevas
    Tziatzios, Georgios
    Leite, Gabriela
    Papanikolaou, Ioannis S. S.
    Xirouchakis, Elias
    Panayiotides, Ioannis G. G.
    Karageorgos, Athanasios
    Millan, Maria Jesus
    Mathur, Ruchi
    Weitsman, Stacy
    Dimitriadis, George D. D.
    Giamarellos-Bourboulis, Evangelos J. J.
    Pimentel, Mark
    Triantafyllou, Konstantinos
    MICROORGANISMS, 2023, 11 (03)
  • [10] Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study
    Akahane, Takemi
    Akahane, Manabu
    Namisaki, Tadashi
    Kaji, Kosuke
    Moriya, Kei
    Kawaratani, Hideto
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Shimozato, Naotaka
    Fujinaga, Yukihisa
    Furukawa, Masanori
    Kitagawa, Koh
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Kaya, Daisuke
    Mitoro, Akira
    Yoshiji, Hitoshi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)